{"id":"W1977694976","doi":"10.1185/03007995.2013.836078","title":"Health-related quality of life and disease symptoms in postmenopausal women with HR+, HER2−advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapy","year":2013,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital du Saint-Sacrement; Sunnybrook Health Science Centre; University of Toronto","funders":"European Society for Medical Oncology; Novartis Pharmaceuticals Corporation","keywords":"Medicine; Exemestane; Discontinuation; Internal medicine; Breast cancer; Quality of life (healthcare); Placebo; Confidence interval; Aromatase inhibitor; Hazard ratio; Oncology; Cancer; Aromatase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001076433,0.0002444112,0.0007726225,0.0001472942,0.00009731119,0.0002577495,0.0001434233,0.0002866876,0.001236982],"category_scores_gemma":[0.001204893,0.0001350671,0.0006675762,0.0001698554,0.000160072,0.0002195486,0.0001838019,0.0003287795,0.000103573],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002316453,"about_ca_system_score_gemma":0.000173964,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003577447,"about_ca_topic_score_gemma":0.0007219961,"domain_scores_codex":[0.9996647,0.0001837262,0.00002946642,0.00004160003,0.00004796136,0.00003272296],"domain_scores_gemma":[0.999661,0.0001092166,0.0001288154,0.00001676058,0.00001797253,0.00006627208],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.438114,0.006724817,0.3820048,0.001328321,0.006847796,0.0002010866,0.0005016975,0.002574507,0.02153017,0.00009069104,0.0009202724,0.1391618],"study_design_scores_gemma":[0.01512777,0.07204252,0.9060471,0.00004990175,0.001766047,0.0002661915,0.0001373443,0.001748679,0.001839735,0.0001264062,0.0008259176,0.00002229887],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9985105,0.001099748,0.00003431313,0.00004448035,0.000007386786,0.00002367787,0.0001151468,0.000002195502,0.0001625096],"genre_scores_gemma":[0.9994394,0.0001894258,0.00006568812,0.00003924463,0.00001026801,0.00003977906,0.00009211851,6.340662e-7,0.0001233179],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001236982,"threshold_uncertainty_score":0.00569278,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04616009174512354,"score_gpt":0.3891158325754402,"score_spread":0.3429557408303167,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}